Group items tagged

The high-end data based capabilities of LTE technology comprise one of the major growth drivers of the global public safety LTE market. Almost all the major telecom network operators are signing up for LTE technology in their respective service networks. However, omnipresent Professional Mobile Radio (PMR) technologies could pose a serious challenge to the future growth of this market. That is because PMR technologies for public safety have always enjoyed a rather strong presence in the public safety industry. These are used extensively in different parts of the world and find applications in different domains ranging from police services to ports.

Segmentation of the motor vehicle part markets in Eastern Europe by product types reveals the fast growing products. Latest trends indicate bright future prospects and unfold emerging opportunities. Important product segments include axles, brakes and servo-brakes, bumpers, clutches, exhaust pipes and silencers, gear boxes, parts for diesel and semi-diesel engines, parts for spark-ignition engines, radiators, safety seat belts, shock-absorbers, steering wheels, steering boxes and steering columns and wheels.

A complete picture of the historic development, current market situation and trends enables product managers and analysts track industry trends and identify market prospects in different countries easily. Key market information assists marketers to plan and develop marketing, market-entry, expansion and other business strategies. The global plastic headgear market is expected to register strong growth in the near future. The popularity of safety headgear of plastic can be attributed to the rapid growth of the market.

The global commercial helicopter sector is expected to experience a growth of 3.08% growth during 2013 to 2023. The commercial helicopter market grows on the back of several sectors worldwide including offshore oil and gas exploration and production, HEMS, VIP transport, law enforcement and public safety etc. Emerging markets of Asia Pacific, Latin America and Middle East are expected to provide the necessary boost to the industry during 2013 to 2023.

With conventional corticosteroid treatment being effective in only 50-60% of patients, development of new treatment options is necessary to cover the unmet needs of the uveitis market. The market is currently dominated by corticosteroid treatment options and off-label immunosuppressive and biologic drugs. Although anterior uveitis patients constitute the major share of patients, except one, all the new treatments in late stage clinical development target the intermediate, posterior and pan uveitis patient segment. Drugs capable of permanently inhibiting ocular inflammation as well as offering an improved safety profile will have a significant impact on the uveitis market.